HOME >> BIOLOGY >> NEWS
Screening programs find health problems among former Hanford workers

A press conference to outline the results of medical screenings of former Hanford workers will be held at 11 a.m. PST on Tuesday, Nov. 2, in the Columbia Room of the Richland Red Lion (formerly the DoubleTree).

The conference is sponsored by the University of Washington, The Coalition to Protect Workers' Rights, and the Department of Energy.

The conference will include representatives of those groups, plus former workers who will be available for interviews. Media unable to attend the conference can obtain information about the results, after the briefing, by calling the number above.

The two projects involved have screened about 600 workers so far, with plans to screen an additional 20,000 for health problems related to their work at the Hanford nuclear site in southeastern Washington state. These evaluations are the most extensive of former Hanford workers to date.

Undiagnosed lung disease and hearing loss are the most common ailments noted thus far.

The conference comes at the beginning of the third annual "Health of the Hanford Site" conference sponsored by the University of Washington. The data on former workers will be presented in full along with other topics related to human and ecological health at Hanford. The conference gives scientists, contractors, workers, residents, tribal representatives and others an opportunity to exchange information and discuss past, present and future research regarding the site.

Members of the media are welcome to cover some or all of the conference, also held at the Red Lion. For more information, call the number above or visit the conference Web site at http://depts.washington.edu/cresp2/hos. Besides worker health, other topics at the conference will include contaminated high-level waste tanks, beryllium exposure and evaluation of human and ecological health risks.

Among the scheduled topics:

    - The two new studies that quantify the number of health problems that have affected
    '"/>


Contact: Walter Neary
wneary@u.washington.edu
206-543-3620
University of Washington
26-Oct-1999


Page: 1 2

Related biology news :

1. Society for Biomolecular Screening to hold ninth annual conference
2. Screening technique streamlines search for anticancer drugs
3. Screening certain infants can be lifesaving, Wake Forest study shows
4. Screening embryos for problem chromosomes
5. American Red Cross Launches New Genetic Screening Technology To Directly Detect Viruses
6. H Pylori Screening To Reduce The Risk Of Gastric Cancer
7. Vibrating Cells Could Be The Ultimate In Noninvasive Screening
8. Screening In Women Army Recruits Shows High Chlamydia Infection Rates
9. Researchers Develop Fast Screening Method For Water Testing
10. Genetic Screening May Be Tool For Selecting Cancer Treatment, Research Suggests
11. Cancer Test May Offer High-Risk Groups Quick, Affordable Screening For Tumors

Post Your Comments:
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global leader ... series of digital telemetry implants to meet the ... part of the PhysioTel™ Digital platform, was designed ... data when incorporating functional endpoints into repeat-dose toxicology ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE San Diego ... provides the connective tissue that enhances care coordination among social ... client-level information; earned a second $1 million grant from the ... in community and; will be recognized as a "Live Well ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
(Date:1/22/2015)... January 22, 2015 Pipette.com has added ... to their comprehensive portfolio of Eppendorf products. , The ... purchase a Centrifuge 5424/5424 R and receive the following:, ... Eppendorf Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)...  Varian Medical Systems (NYSE: VAR ), world leader ... commitment to sustainability with inclusion on a prestigious list of ... healthcare equipment company among the Corporate Knights Global 100 Most ... at Davos, Switzerland . ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
Cached News: